CHA Biotech's subsidiary CHA Vaccine announced on the 8th that it will jointly develop messenger ribonucleic acid (mRNA) vaccines and therapeutics with SML Biopharm. mRNA serves as a 'messenger' that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback